Biosense Webster wins purchase agreement with Novation:
This article was originally published in Clinica
Johnson & Johnson subsidiary Biosense Webster has signed a purchasing agreement for its electrophysiology catheters with Novation. The agreement covers both diagnostic and therapeutic catheters. The deal takes place immediately and will run until the end of September 2002. Novation, which is headquartered in Irving, Texas, manages over $12 billion in supply purchases for around 6,400 healthcare organisations in the US.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.